You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Driving Excellence in Approaches to Multiple Myeloma 3 (DREAMM 3)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Birmingham, Alabama
  • +25 more
Dec 9, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
Jul 27, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Daratumumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Yuma, Arizona
  • +150 more
Dec 9, 2022

Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Orlando, Florida
  • +240 more
Aug 18, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Pom/dex (Pomalidomide plus low dose Dexamethasone)
  • Tucson, Arizona
  • +163 more
Feb 25, 2022

Multiple Myeloma Trial (Bela, Belamaf, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jan 27, 2023

Relapsed/Refractory Multiple Myeloma Trial in United States (Belantamab mafodotin)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Belantamab mafodotin
  • Clayton, North Carolina
  • +4 more
May 16, 2023

Multiple Myeloma, Refractory Trial in Washington, Hackensack, Neptune (Pembrolizumab, Belantamab mafodotin, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma, Refractory
  • Washington, District of Columbia
  • +2 more
Aug 5, 2022

Smoldering Multiple Myeloma Trial (Selinexor)

Not yet recruiting
  • Smoldering Multiple Myeloma
  • (no location specified)
Oct 27, 2022

Smoldering Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Daratumumab)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Tampa, Florida
  • +9 more
Jul 8, 2022

Multiple Myeloma Trial in New Haven (Elotuzumab, Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 15, 2022

Learn How Triple Class Refractory Multiple Myeloma Are Treated

Not yet recruiting
  • Relapse Multiple Myeloma
  • Refractory Multiple Myeloma
    • (no location specified)
    Feb 15, 2023

    Multiple Myeloma Trial in Greece, Korea, Republic of, United States (Belantamab mafodotin)

    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • Tucson, Arizona
    • +21 more
    Jul 20, 2022

    Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Bortezomib, Lenalidomide)

    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • +3 more
    • Yuma, Arizona
    • +34 more
    Jul 22, 2022

    Multiple Myeloma Trial in Milan (Temferon)

    Terminated
    Has Results
    • Multiple Myeloma
    • Milan, Italy
      Ospedale San Raffaele
    Jan 27, 2022

    High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

    Not yet recruiting
    • High-Risk de Novo Multiple Myeloma
    • Badalona, Spain
    • +9 more
    Apr 27, 2023

    ISS Stage III Plasma Cell Myeloma, Plasma Cell Myeloma Trial in Rochester (procedure, drug, biological)

    Not yet recruiting
    • ISS Stage III Plasma Cell Myeloma
    • Plasma Cell Myeloma
    • Bone Marrow Aspiration and Biopsy
    • +7 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 9, 2022

    Relapsed or Refractory Multiple Myeloma Trial (Talquetamab)

    Available
    • Relapsed or Refractory Multiple Myeloma
    • (no location specified)
    Mar 6, 2023

    Relapsed, Refractory Multiple Myeloma Trial in Milwaukee (RAPA-201 Autologous T cells)

    Recruiting
    • Relapsed, Refractory Multiple Myeloma
    • RAPA-201 Autologous T cells
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Dec 28, 2021

    Multiple Myeloma Trial in Worldwide (Belantamab mafodotin)

    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • New Port Richey, Florida
    • +94 more
    Nov 30, 2022

    Multiple Myeloma Trial in Philadelphia (Planned Notification, Survey Administration, Behavioral Intervention)

    Recruiting
    • Multiple Myeloma
    • Planned Notification
    • +4 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Sep 11, 2023

    Relapsed/Refractory Multiple Myeloma Trial in Worldwide (Placebo, Bortezomib, Dexamethasone)

    Completed
    • Relapsed/Refractory Multiple Myeloma
    • Placebo
    • +3 more
    • Aurora, Colorado
    • +96 more
    Aug 22, 2022

    Relapsed/Refractory Multiple Myeloma Trial in Baltimore (Belantamab Mafodotin, Cyclophosphamide and Dexamethasone)

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Belantamab Mafodotin, Cyclophosphamide and Dexamethasone
    • Baltimore, Maryland
      University of Maryland
    Jan 24, 2022

    Relapsed Multiple Myeloma Trial in Spain (Belantamab mafodotin, Carfilzomib, Dexamethasone)

    Recruiting
    • Relapsed Multiple Myeloma
    • Belantamab mafodotin
    • +2 more
    • Badalona, Spain
    • +14 more
    Sep 5, 2022

    Belantamab Mafodotin in Relapsed and/or Refractory Multiple

    Recruiting
    • RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
    • Belantamab mafodotin
    • Albacete, Spain
    • +61 more
    Aug 2, 2022